AZN made a $7 Billion deal for a cancer partnership -- this is essentially a delivery system to get chemotherapy drugs inside cancer cells in a certain patient population, breast and gastric cancers involving the HER2 pathway.

https://endpts.com/astrazeneca-ceo-soriot-bet...ncer-drug/

That means, of course, that they are still following the existing model of poisoning the patient to cure them, whereas a p53 drug might obviate the need for chemo. Or it's possible that Kevetrin plus this technology could knock out cancer fast.